Form 4 for DGX Quest Diagnostics
Accepted 2026-07-27 16:35:39 ET · period of report 2026-07-22 · accession 0001022079-26-000086 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-27 16:35 | 2026-07-22 | DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | L - Small Acq | $206.81 | +37 | 13.6K | +0.3% | +$7,652 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-22 | L | A | 37 | $206.81 | 13,557 | D | — | — | (F1) Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. (F2) The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. |